| Year |
Citation |
Score |
| 2020 |
Sabedot T, Malta T, Snyder J, Nelson K, Wells M, deCarvalho A, Mukherjee A, Chitale D, Mosella M, Asmaro K, Robin A, Rosenblum M, Mikkelsen T, Rock J, Poisson L, et al. Abstract A10: Glioma cell-free DNA methylation marker for diagnosis and monitoring Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Liqbiop20-A10 |
0.332 |
|
| 2019 |
Castro AV, Wells M, Asmaro K, Sabedot TS, Mosella MS, Malta TM, Nelson K, Snyder J, deCarvalho A, Mukherjee A, Chitale D, Robin A, Rosenblum M, Mikkelsen T, Poisson LM, et al. P01.02 Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors Neuro-Oncology. 21: iii24-iii24. DOI: 10.1093/Neuonc/Noz126.080 |
0.358 |
|
| 2019 |
Noushmehr H, Sabedot T, Malta T, Nelson K, Snyder J, Wells M, deCarvalho A, Mukherjee A, Chitale D, Mosella M, Asmaro K, Robin A, Rosenblum M, Mikkelsen T, Rock J, et al. OS1.5 Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers Neuro-Oncology. 21: iii6-iii6. DOI: 10.1093/Neuonc/Noz126.018 |
0.361 |
|
| 2015 |
Ali R, Pabaney A, Robin A, Marin H, Rosenblum M. Glioblastoma and intracranial aneurysms: Case report and review of literature. Surgical Neurology International. 6: 66. PMID 25969791 DOI: 10.4103/2152-7806.155759 |
0.308 |
|
| 2014 |
Mazaris P, Hong X, Altshuler D, Schultz L, Poisson LM, Jain R, Mikkelsen T, Rosenblum M, Kalkanis S. Key determinants of short-term and long-term glioblastoma survival: a 14-year retrospective study of patients from the Hermelin Brain Tumor Center at Henry Ford Hospital. Clinical Neurology and Neurosurgery. 120: 103-12. PMID 24731587 DOI: 10.1016/J.Clineuro.2014.03.001 |
0.36 |
|
| 2014 |
Kim EY, Yechieli R, Kim JK, Mikkelsen T, Kalkanis SN, Rock J, Rosenblum M, Ryu S. Patterns of failure after radiosurgery to two different target volumes of enhancing lesions with and without FLAIR abnormalities in recurrent glioblastoma multiforme. Journal of Neuro-Oncology. 116: 291-7. PMID 24173682 DOI: 10.1007/S11060-013-1290-4 |
0.383 |
|
| 2014 |
Rosenblum ML, Robin A, Walbert T, Mikkelsen T, Kalkanis S, Rosenblum M. Brain Tumor Care Through The Patient'S Eyes — The Value Of A Comprehensive Brain Tumor Center Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou209.31 |
0.304 |
|
| 2013 |
Saksena S, Jain R, Schultz L, Jiang Q, Soltanian-Zadeh H, Scarpace L, Rosenblum M, Mikkelsen T, Nazem-Zadeh MR. The Corpus Callosum Wallerian Degeneration in the Unilateral Brain Tumors: Evaluation with Diffusion Tensor Imaging (DTI). Journal of Clinical and Diagnostic Research : Jcdr. 7: 320-5. PMID 23543618 DOI: 10.7860/Jcdr/2013/4491.2757 |
0.338 |
|
| 2012 |
Robbins JR, Ryu S, Kalkanis S, Cogan C, Rock J, Movsas B, Kim JH, Rosenblum M. Radiosurgery to the surgical cavity as adjuvant therapy for resected brain metastasis. Neurosurgery. 71: 937-43. PMID 22806080 DOI: 10.1227/Neu.0B013E31826909F2 |
0.349 |
|
| 2012 |
Nazem-Zadeh MR, Saksena S, Babajani-Fermi A, Jiang Q, Soltanian-Zadeh H, Rosenblum M, Mikkelsen T, Jain R. Segmentation of corpus callosum using diffusion tensor imaging: validation in patients with glioblastoma. Bmc Medical Imaging. 12: 10. PMID 22591335 DOI: 10.1186/1471-2342-12-10 |
0.309 |
|
| 2011 |
Jain R, Narang J, Gutierrez J, Schultz LR, Scarpace L, Rosenblum M, Mikkelsen T, Rock JP. Correlation of immunohistologic and perfusion vascular parameters with MR contrast enhancement using image-guided biopsy specimens in gliomas. Academic Radiology. 18: 955-62. PMID 21718954 DOI: 10.1016/J.Acra.2011.04.003 |
0.302 |
|
| 2011 |
Jain R, Narang J, Schultz L, Scarpace L, Saksena S, Brown S, Rock JP, Rosenblum M, Gutierrez J, Mikkelsen T. Permeability estimates in histopathology-proved treatment-induced necrosis using perfusion CT: can these add to other perfusion parameters in differentiating from recurrent/progressive tumors? Ajnr. American Journal of Neuroradiology. 32: 658-63. PMID 21330392 DOI: 10.3174/Ajnr.A2378 |
0.353 |
|
| 2011 |
Narang J, Jain R, Scarpace L, Saksena S, Schultz LR, Rock JP, Rosenblum M, Patel SC, Mikkelsen T. Tumor vascular leakiness and blood volume estimates in oligodendrogliomas using perfusion CT: an analysis of perfusion parameters helping further characterize genetic subtypes as well as differentiate from astroglial tumors. Journal of Neuro-Oncology. 102: 287-93. PMID 20680399 DOI: 10.1007/S11060-010-0317-3 |
0.348 |
|
| 2010 |
Schipani S, Jain R, Shah K, Rock JP, Movsas B, Rosenblum M, Ryu S. Clinical, dosimetric, and radiographic correlation of radiation injury involving the brainstem and the medial temporal lobes following stereotactic radiotherapy for neoplasms of central skull base. Journal of Neuro-Oncology. 98: 177-84. PMID 20376551 DOI: 10.1007/S11060-010-0171-3 |
0.375 |
|
| 2010 |
Ryu S, Rock J, Jain R, Lu M, Anderson J, Jin JY, Rosenblum M, Movsas B, Kim JH. Radiosurgical decompression of metastatic epidural compression. Cancer. 116: 2250-7. PMID 20209611 DOI: 10.1002/Cncr.24993 |
0.406 |
|
| 2010 |
Torcuator RG, Thind R, Patel M, Mohan YS, Anderson J, Doyle T, Ryu S, Jain R, Schultz L, Rosenblum M, Mikkelsen T. The role of salvage reirradiation for malignant gliomas that progress on bevacizumab. Journal of Neuro-Oncology. 97: 401-7. PMID 19838627 DOI: 10.1007/S11060-009-0034-Y |
0.348 |
|
| 2009 |
Torcuator R, Zuniga R, Mohan YS, Rock J, Doyle T, Anderson J, Gutierrez J, Ryu S, Jain R, Rosenblum M, Mikkelsen T. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. Journal of Neuro-Oncology. 94: 63-8. PMID 19189055 DOI: 10.1007/S11060-009-9801-Z |
0.318 |
|
| 2009 |
Patel M, Siddiqui F, Jin JY, Mikkelsen T, Rosenblum M, Movsas B, Ryu S. Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival. Journal of Neuro-Oncology. 92: 185-91. PMID 19066727 DOI: 10.1007/S11060-008-9752-9 |
0.311 |
|
| 2008 |
Li A, Walling J, Kotliarov Y, Center A, Steed ME, Ahn SJ, Rosenblum M, Mikkelsen T, Zenklusen JC, Fine HA. Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas. Molecular Cancer Research : McR. 6: 21-30. PMID 18184972 DOI: 10.1158/1541-7786.Mcr-07-0280 |
0.325 |
|
| 2008 |
Zuniga RM, Torcuator R, Doyle T, Anderson J, Jain R, Orley J, Rosenblum M, Mikkelsen T. Retrospective analysis of patterns of recurrence seen on MRI in patients with recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan Journal of Clinical Oncology. 26: 13013-13013. DOI: 10.1200/Jco.2008.26.15_Suppl.13013 |
0.372 |
|
| 2006 |
Kotliarov Y, Steed ME, Christopher N, Walling J, Su Q, Center A, Heiss J, Rosenblum M, Mikkelsen T, Zenklusen JC, Fine HA. High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. Cancer Research. 66: 9428-36. PMID 17018597 DOI: 10.1158/0008-5472.Can-06-1691 |
0.349 |
|
| 2004 |
Yin FF, Ryu S, Ajlouni M, Yan H, Jin JY, Lee SW, Kim J, Rock J, Rosenblum M, Kim JH. Image-guided procedures for intensity-modulated spinal radiosurgery. Technical note. Journal of Neurosurgery. 101: 419-24. PMID 15537199 DOI: 10.3171/Jns.2004.101.Supplement_3.0419 |
0.357 |
|
| 2004 |
Chiocca EA, Abbed KM, Tatter S, Louis DN, Hochberg FH, Barker F, Kracher J, Grossman SA, Fisher JD, Carson K, Rosenblum M, Mikkelsen T, Olson J, Markert J, Rosenfeld S, et al. A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 958-66. PMID 15509513 DOI: 10.1016/J.Ymthe.2004.07.021 |
0.317 |
|
| 2004 |
Rock JP, Scarpace L, Hearshen D, Gutierrez J, Fisher JL, Rosenblum M, Mikkelsen T. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis. Neurosurgery. 54: 1111-7; discussion 1. PMID 15113465 DOI: 10.1227/01.Neu.0000119328.56431.A7 |
0.39 |
|
| 2002 |
Yin FF, Ryu S, Ajlouni M, Zhu J, Yan H, Guan H, Faber K, Rock J, Abdalhak M, Rogers L, Rosenblum M, Kim JH. A technique of intensity-modulated radiosurgery (IMRS) for spinal tumors. Medical Physics. 29: 2815-22. PMID 12512715 DOI: 10.1118/1.1521722 |
0.309 |
|
| 2002 |
Bogler O, Finniss S, Kittiniyom K, Rempel S, Rosenblum M, Mikkelsen T, Newsham I. Studying the heterogeneity of brain tumors using medium throughput LOH analysis. Cytometry. 47: 52-5. PMID 11774351 DOI: 10.1002/Cyto.10035 |
0.381 |
|
| 1994 |
DeArmond SJ, Stowring L, Amar A, Coopersmith P, Dougherty D, Spencer D, Mikkelsen T, Rosenblum M. Development of a non-selecting, non-perturbing method to study human brain tumor cell invasion in murine brain Journal of Neuro-Oncology. 20: 27-34. PMID 7807181 DOI: 10.1007/Bf01057958 |
0.378 |
|
| 1989 |
LaRocca RV, Rosenblum M, Westermark B, Israel MA. Patterns of proto-oncogene expression in human glioma cell lines Journal of Neuroscience Research. 24: 97-106. PMID 2810398 DOI: 10.1002/Jnr.490240114 |
0.301 |
|
| 1983 |
Talcott RE, Rosenblum M, Levin VA. Possible role of DT-diaphorase in the bioactivation of antitumor quinones. Biochemical and Biophysical Research Communications. 111: 346-351. PMID 6187345 DOI: 10.1016/S0006-291X(83)80158-2 |
0.313 |
|
| Show low-probability matches. |